NCT04201249

Mesotherapy In Lateral Epicondylitis

MILES STUDY - Mesotherapy In Lateral Epicondylitis, a Prospective Randomized Controlled Study

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 82 (estimated)
• Sponsor: Hospital de Santa Maria, Portugal · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Investigate the short- and long-term efficacy and safety of intradermal NSAIDs and lidocaine (delivered through mesotherapy) for the treatment of LE comparing it with empty intradermal injections.

Conditions

• Lateral Epicondylitis

Interventions

Type	Name	Description
DRUG	Piroxicam, lidocaine	Patients will be randomized to 2 groups group A - mesotherapy with piroxicam (20mg/ml, 1ml) and lidocaine (1%, 1.5ml) (treatment arm); group group B - mesotherapy without piroxicam
DEVICE	Mesotherapy without drug administration	Patients will be randomized to 2 groups group A - mesotherapy with piroxicam (20mg/ml, 1ml) and lidocaine (1%, 1.5ml) (treatment arm); group group B - mesotherapy without piroxicam

Timeline

• Start date: 2019-12-01
• Primary completion: 2021-12-12
• Completion: 2021-12-12
• First posted: 2019-12-17
• Last updated: 2019-12-18

Locations

1 site across 1 country: Portugal